Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
39.76
+0.04 (0.10%)
Jun 15, 2026, 4:00 PM EDT - Market closed
Centessa Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 11, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Apr 20, 2026 |
| Wells Fargo | Wells Fargo | Hold Downgrades $42 | Hold | Downgrades | $42 | +5.63% | Apr 20, 2026 |
| Truist Financial | Truist Financial | Hold Downgrades $38 | Hold | Downgrades | $38 | -4.43% | Apr 13, 2026 |
| Guggenheim | Guggenheim | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Apr 1, 2026 |
| Wolfe Research | Wolfe Research | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Apr 1, 2026 |
| LifeSci Capital | LifeSci Capital | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Apr 1, 2026 |
| Leerink Partners | Leerink Partners | Hold Downgrades $40 | Hold | Downgrades | $40 | +0.60% | Apr 1, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.